Hikma Pharma to meet investors for potential dollar bond -leads

DUBAI, March 25 (Reuters) - Hikma Pharmaceuticals Plc, a drugs group founded in Jordan in 1978, has pickedfour banks to arrange a series of fixed income meetings startingFriday for a potential benchmark dollar bond, a document fromlead arrangers showed.

The company has picked Citigroup, Barclays, HSBC andNational Bank of Abu Dhabi to arrange investor meetings inEurope and the Middle East, the document stated.

Hikma, rated BB+ Standard and Poor's and Ba1 by Moody's,joined Britain's benchmark FTSE 100 equity index inMarch. Getting into the FTSE 100 can often fuel further demandfor a company's shares, since funds that track the FTSE orinvest in the index can then add that stock to their portfolio. (Reporting by Archana Narayanan; editing by Matt Smith)